UNIVERSITY OF PENNSYLVANIA MASTER SPONSORED RESEARCH AGREEMENTMaster Sponsored Research Agreement • August 1st, 2018 • Ophthotech Corp. • Pharmaceutical preparations • Pennsylvania
This Sponsored Research Agreement (“Agreement”) is dated as of June 6, 2018 (the “Effective Date”) by and between The Trustees of the University of Pennsylvania, a Pennsylvania nonprofit corporation (“Penn”), with offices located at Penn Center for Innovation, 3160 Chestnut Street, Suite 200, Philadelphia, PA 19104-6283, and Ophthotech Corporation, a Delaware corporation (“Sponsor”), having a place of business at One Penn Plaza, Suite 3520, New York, NY 10119. Penn and Sponsor may be referred to herein as a “Party” or, collectively, as “Parties”.
SIXTH AMENDMENT OF LEASELease • August 1st, 2018 • Ophthotech Corp. • Pharmaceutical preparations
THIS SIXTH AMENDMENT OF LEASE, made as of the 29th day of June, 2018 (this "Amendment"), by and between ONE PENN PLAZA LLC, a New York limited liability company, having an office c/o Vornado Office Management LLC, 888 Seventh Avenue, New York, New York 10019 ("Landlord"), and OPHTHOTECH CORPORATION, a Delaware corporation, having an office at One Penn Plaza, New York, New York 10019 ("Tenant").
One Penn Plaza, 35th Floor New York, NY 10119Ophthotech Corp. • August 1st, 2018 • Pharmaceutical preparations
For good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, subject to your execution below, this letter hereby further amends the employment letter, dated April 26, 2013, between you and Ophthotech Corporation (the “Company”), as amended by letters dated February 26, 2015, April 24, 2017 and May 12, 2018, between you and the Company (as amended, the “Employment Letter”) by making the following changes:
One Penn Plaza, 35th Floor New York, NY 10119Ophthotech Corp. • August 1st, 2018 • Pharmaceutical preparations
For good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, subject to your execution below, this letter hereby further amends the employment letter, dated April 26, 2013, between you and Ophthotech Corporation (the “Company”), as amended by letters dated February 26, 2015 and April 24, 2017 between you and the Company (as amended, the “Employment Letter”) by making the following change:
EXCLUSIVE LICENSE AGREEMENT WITH KNOW-HOW Agreement No: A18025 By and among The University of Florida Research Foundation, Incorporated, and The Trustees of the University of Pennsylvania, acting as a single party (the “Licensors”) and Ophthotech...Ophthotech Corp. • August 1st, 2018 • Pharmaceutical preparations • Florida
This Agreement is effective as of June 6, 2018, (the “Effective Date”) among the University of Florida Research Foundation, Incorporated, a nonstock, nonprofit Florida corporation with offices located at 223 Grinter Hall, Gainesville, Florida 32611 (hereinafter called “UFRF”) and the Trustees of the University of Pennsylvania, a Pennsylvania nonprofit corporation, with offices located at Penn Center for Innovation, 3160 Chestnut Street, Suite 200, Philadelphia, PA 19104-6283 (“Penn”, together with UFRF, the “Licensors”), and Ophthotech Corporation, a Delaware corporation, having a place of business at One Penn Plaza, Suite 3520, New York, NY 10119 (hereinafter called “Licensee”).
